Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
4
Bullish
7
Bearish
25
Neutral
4
Bullish
17
Bearish
22
Neutral
0
Bullish
10
Bearish
3
Neutral
4
Bullish
7
Bearish
3
Neutral
4
Bullish
7
Bearish
22
Neutral
0
Bullish
10
Bearish
22
Neutral
0
Bullish
10
Bearish
22
Neutral
0
Bullish
10
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Transpek Industry Ltd (TRANSPEK) is currently trading at 1,266.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Transpek Industry Limited is a specialty chemical manufacturer focused on chlorinated and sulfur chemistries supplying intermediates and specialty products globally, with strong export orientation into North America and legacy strengths in acid chlorides and thionyl chloride. The company reported Q1 FY27 revenue of INR155.1 crore, a 6.5% decline year‑on‑year, with EBITDA at INR24.1 crore and EBITDA margin of 15.6%; PAT for the quarter was INR8.9 crore, while the balance sheet remains net debt‑free providing capacity to fund planned capex without over‑leverage. Transpek is accelerating product diversification into high value polymers, polymer additives, multi‑step sulfonation intermediates, chloro‑fluoro compounds and electronics/battery chemicals, and plans to double R&D headcount and build a four‑stream multi‑purpose pilot plant to commercialize kilo‑scale output. Exports dominate at ~84% of sales with North America contributing over 52%; the company is focused on reducing polymer end‑user concentration (now ~48% of revenue) through new product launches and specialization that target mission‑critical applications in medical, aerospace, semiconductors and water treatment. A major commercial exposure remains the long‑term supply relationship formerly with DuPont, now assigned to Arclin with renewal discussions scheduled next year; management acknowledges renewal risk but highlights nine years of consistent supply reliability and is preparing mitigation via portfolio diversification.
Over the past 52 weeks, Transpek Industry Ltd has traded between a low of ₹864.00 and a high of ₹1,481.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Transpek Industry Ltd has a market capitalization of approximately 697.64. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Transpek Industry Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.89 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 697.64 Cr, Transpek Industry Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Transpek Industry Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Transpek Industry Ltd is 17.89. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Chemicals & Petrochemicals
Commodity Chemicals
698 Cr
Low Risk
17.9
35.0
-0.6
0.9
1,481.00
864.00
Sales CAGR
Profit CAGR
ROE
ROCE